Architect HBsAg Next Qualitative
Device
Abbott Laboratories
Total Payments
$78,930
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $78,930 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $78,930 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ARCHITECT HBsAg NEXT Alinity | Abbott Laboratories | $71,180 | 0 |
| ARCHITECT HBsAG NEXT and Alinity HBsAG NEXT | Abbott Laboratories | $4,750 | 0 |
| Design Validation Protocol for the Evaluation of Architect HBsAG Next Qualitative and Alinity HBsAG NEXT qualitative Confirmatory Assays | Abbott Laboratories | $3,000 | 0 |
Top Doctors Receiving Payments for Architect HBsAg Next Qualitative
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boca Raton, FL | $78,930 | 3 |
Ad
Manufacturing Companies
- Abbott Laboratories $78,930
Product Information
- Type Device
- Total Payments $78,930
- Total Doctors 0
- Transactions 3
About Architect HBsAg Next Qualitative
Architect HBsAg Next Qualitative is a device associated with $78,930 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $78,930 was paid across 3 transactions to 0 doctors.
The most common payment nature for Architect HBsAg Next Qualitative is "Unspecified" ($78,930, 100.0% of total).
Architect HBsAg Next Qualitative is associated with 3 research studies, including "ARCHITECT HBsAg NEXT Alinity" ($71,180).